Literature DB >> 21197195

Role of oncology clinical pharmacists in light of the oncology workforce study.

Jolynn K Sessions1, John Valgus, Sally Yowell Barbour, Lew Iacovelli.   

Abstract

To date, the information published regarding workforce implications has focused on physicians, nurse practitioners, and physician assistants. But oncology clinical pharmacists also can assist with direct patient care and patient education activities.

Entities:  

Year:  2010        PMID： 21197195      PMCID： PMC2936477          DOI： 10.1200/JOP.000037

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


  3 in total

1.  Physician Assistant Perspective on the ASCO Workforce Study Regarding the Use of Physician Assistants and Nurse Practitioners.

Authors:  Maura Polansky; Alicia C Ross; David Coniglio
Journal:  J Oncol Pract       Date:  2009-12-23       Impact factor: 3.840

2.  Evaluation of clinical pharmacy services in a hematology/oncology outpatient setting.

Authors:  Sachin Shah; Jonathan Dowell; Shane Greene
Journal:  Ann Pharmacother       Date:  2006-08-01       Impact factor: 3.154

3.  Future supply and demand for oncologists : challenges to assuring access to oncology services.

Authors:  Clese Erikson; Edward Salsberg; Gaetano Forte; Suanna Bruinooge; Michael Goldstein
Journal:  J Oncol Pract       Date:  2007-03       Impact factor: 3.840
  3 in total
  12 in total

Review 1.  The need for community pharmacists in oncology outpatient care: a systematic review.

Authors:  Johannes Thoma; Romána Zelkó; Balázs Hankó
Journal:  Int J Clin Pharm       Date:  2016-04-07

Review 2.  Utilization of collaborative practice agreements between physicians and pharmacists as a mechanism to increase capacity to care for hematopoietic stem cell transplant recipients.

Authors:  Julianna A Merten; Jamie F Shapiro; Alison M Gulbis; Kamakshi V Rao; Joseph Bubalo; Scott Lanum; Ashley Morris Engemann; Sepideh Shayani; Casey Williams; Helen Leather; Tracey Walsh-Chocolaad
Journal:  Biol Blood Marrow Transplant       Date:  2013-02-15       Impact factor: 5.742

3.  Comparison between cancer specialists and general physicians regarding the education of nurse practitioners in Japan: a postal survey of the Japanese Society of Clinical Oncology.

Authors:  Yasushi Ishida; Masahiko Hatao; Osamu Fukushima; Michiko Mori; Fumiko Isozaki; Asako Okuyama
Journal:  Int J Clin Oncol       Date:  2012-08-11       Impact factor: 3.402

4.  Prevention and treatment of venous thromboembolism in patients with cancer.

Authors:  William M Semchuk; Catherine Sperlich
Journal:  Can Pharm J (Ott)       Date:  2012-01

5.  Pilot Randomized Trial of a Pharmacy Intervention for Older Adults with Cancer.

Authors:  Ryan D Nipp; Margaret Ruddy; Charn-Xin Fuh; Mark L Zangardi; Christine Chio; E Bridget Kim; Barbara Kong Mui Li; Ying Long; Gayle C Blouin; Daniel Lage; David P Ryan; Joseph A Greer; Areej El-Jawahri; Jennifer S Temel
Journal:  Oncologist       Date:  2018-10-19

6.  Impact of clinical pharmacist services on quality adjusted life years in head and neck cancer patients.

Authors:  Avinash Khadela; Bhavin Vyas; Vishal Bhikadiya; Prakshavi Naik
Journal:  Int J Clin Pharm       Date:  2021-02-02

7.  A cross-sectional study of psychological distress, burnout, and the associated risk factors in hospital pharmacists in Japan.

Authors:  Yuji Higuchi; Masatoshi Inagaki; Toshihiro Koyama; Yoshihisa Kitamura; Toshiaki Sendo; Maiko Fujimori; Yosuke Uchitomi; Norihito Yamada
Journal:  BMC Public Health       Date:  2016-07-08       Impact factor: 3.295

8.  Adherence to Oral Anticancer Medications: Evolving Interprofessional Roles and Pharmacist Workforce Considerations.

Authors:  Gennaro A Paolella; Andrew D Boyd; Scott M Wirth; Sandra Cuellar; Neeta K Venepalli; Stephanie Y Crawford
Journal:  Pharmacy (Basel)       Date:  2018-03-08

9.  A retrospective review of treatment patterns of antiemetic agents for chemotherapy-induced nausea and vomiting.

Authors:  Abdulrahman Alamri; Yousef A Alawlah; Yanru Qiao; Junling Wang
Journal:  SAGE Open Med       Date:  2018-05-01

Review 10.  Regorafenib as a single-agent in the treatment of patients with gastrointestinal tumors: an overview for pharmacists.

Authors:  Jean-Baptiste Rey; Vincent Launay-Vacher; Christophe Tournigand
Journal:  Target Oncol       Date:  2014-09-12       Impact factor: 4.493
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.